Dynamic nature of braf or kras p.G12c mutations in second-line therapy for advanced colorectal cancer patients: do early and late effects exist?
Publication date:
2024
Publisher version:
Citación:
British Journal of Cancer, 130(5), p. 777-787 (2024); doi:10.1038/s41416-023-02563-w
Descripción física:
p. 777-787
ISSN:
Patrocinado por:
The study has been funded by Roche and Sanofi Spain.
Collections
- Artículos [36890]